Surgery Branch
Gastrointestinal Oncology and Hepatobiliary Section
Staff Clinician

National Cancer Institute
Building 10 - Magnuson Clinical Center,
Room 3C428
10 Center Drive
Bethesda, MD 20892

Phone: 301-496-4164
pandalaipk@mail.nih.gov

Dr. Pandalai received his B.S. from the University of Michigan in 1997 and his M.D. from Wright State University School of Medicine in 2001. He completed general surgery residency at the University of Cincinnati in 2008 and a fellowship in surgical oncology at the Dana Farber Cancer Institute and Harvard Medical School in 2010. His research interests include G protein-coupled signaling in GI and hepatobiliary malignancy, familial hereditary gastric cancer, and regional chemotherapy for pancreatic cancer. His clinical interests include management of malignancies of the liver, pancreas, and gastrointestinal track, as well as soft tissue and retroperitoneal sarcoma. Additionally he is a commissioned officer in the United States Army Reserve and recently served with the 352nd Combat Support Hospital (FWD) in Afghanistan.

Dr. Pandalai's Clinical Trial(s):

NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with digestive/gastrointestinal cancers. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.

Phase II Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer NCI-13-C-0126, NCT01856322